128 related articles for article (PubMed ID: 17214328)
1. Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.
Ohashi K; Kiura K; Takigawa N; Mizushima T; Ino H; Tabata M; Ueoka H; Tanimoto M
Anticancer Res; 2006; 26(6C):4695-6. PubMed ID: 17214328
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K
Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926
[TBL] [Abstract][Full Text] [Related]
3. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
4. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
[TBL] [Abstract][Full Text] [Related]
5. Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
Edelman MJ; Belani CP; Socinski MA; Ansari RH; Obasaju CK; Chen R; Monberg MJ; Treat J;
J Thorac Oncol; 2010 Jan; 5(1):110-6. PubMed ID: 20035187
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].
Tambo Y; Kasahara K; Fujimura M; Tamori S; Araya T; Sone T; Nakao S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):217-9. PubMed ID: 17301530
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK
J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Danson S; Middleton MR; O'Byrne KJ; Clemons M; Ranson M; Hassan J; Anderson H; Burt PA; Fairve-Finn C; Stout R; Dowd I; Ashcroft L; Beresford C; Thatcher N
Cancer; 2003 Aug; 98(3):542-53. PubMed ID: 12879472
[TBL] [Abstract][Full Text] [Related]
9. Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.
Paramanathan A; Solomon B; Collins M; Franco M; Kofoed S; Francis H; Ball D; Mileshkin L
Clin Lung Cancer; 2013 Sep; 14(5):508-12. PubMed ID: 23792009
[TBL] [Abstract][Full Text] [Related]
10. [Solitary metachnonous jejunum and duodenum metastasis after surgical resection of lung cancer].
Hirai S; Hamanaka Y; Mitsui N; Sato K; Chatani N
Kyobu Geka; 2010 Feb; 63(2):129-32. PubMed ID: 20141081
[TBL] [Abstract][Full Text] [Related]
11. [A 65-year-old man with liver metastases after lung cancer resection that responded to concomitant use of gemcitabine and carboplatin].
Kawabe M; Sasaki M; Hirai S; Ikeda T; Sasaki H; Yoshida M; Amaya H; Aotake T; Uchinami M; Ihaya A; Tanaka K
Gan To Kagaku Ryoho; 2006 Jan; 33(1):69-71. PubMed ID: 16410700
[TBL] [Abstract][Full Text] [Related]
12. Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy.
Leggas M; Kuo KL; Robert F; Cloud G; deShazo M; Zhang R; Li M; Wang H; Davidson S; Rinehart J
Cancer Chemother Pharmacol; 2009 Mar; 63(4):731-43. PubMed ID: 18500521
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
Bepler G; Dilling TJ; Wagner H; Hazelton T; Williams C; Chen DT; Greenberg H; Walsh F; Simon G; Tanvetyanon T; Chiappori A; Haura E; Stevens C
J Thorac Oncol; 2011 Mar; 6(3):553-8. PubMed ID: 21289520
[TBL] [Abstract][Full Text] [Related]
14. Associations between TS, TTF-1, FR-α, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy.
Grønberg BH; Lund-Iversen M; Strøm EH; Brustugun OT; Scott H
J Thorac Oncol; 2013 Oct; 8(10):1255-64. PubMed ID: 24457236
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Chiappori A; Simon G; Williams C; Haura E; Rocha-Lima C; Wagner H; Bepler G; Antonia S
Oncology; 2005; 68(4-6):382-90. PubMed ID: 16020967
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer.
Hardy D; Cormier JN; Xing Y; Liu CC; Xia R; Du XL
J Thorac Oncol; 2010 Jan; 5(1):90-8. PubMed ID: 19884853
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.
Giannitto GC; Giuffrida D; Pappalardo A; Russo A; Vincenzi B; Saita S; Potenza E; Marletta F; La Venia G; Castorina S; Bordonaro R
Oncology; 2005; 69(4):295-300. PubMed ID: 16282709
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features.
Iyoda A; Hiroshima K; Toyozaki T; Haga Y; Baba M; Fujisawa T; Ohwada H
Cancer; 2001 Sep; 92(5):1108-12. PubMed ID: 11571722
[TBL] [Abstract][Full Text] [Related]
19. [A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].
Nagashima O; Tajima K; Ito J; Kajiyama Y; Shimanuki Y; Miura K; Sato K; Miyamoto H; Uekusa T; Suzuki T; Takahashi K; Fukuchi Y
Nihon Kokyuki Gakkai Zasshi; 2006 Mar; 44(3):215-9. PubMed ID: 16617866
[TBL] [Abstract][Full Text] [Related]
20. Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
Sjøblom B; Benth JŠ; Grønberg BH; Baracos VE; Sawyer MB; Fløtten Ø; Hjermstad MJ; Aass N; Jordhøy M
Clin Lung Cancer; 2017 Mar; 18(2):e129-e136. PubMed ID: 27825639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
